Drug target · LYN
Lyn
LYN proto-oncogene, Src family tyrosine kinase
1 compound in the CNS pipeline acts on Lyn.
Compounds targeting Lyn
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| MasitinibSmall molecule | Inhibitor | IC50 510 nM | Phase 3Amyotrophic lateral sclerosis | AB Science |